Omda AS OMDA
Oslo Børs · Healthcare · Health Information Services
44.90 NOK
−0.2%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Omda
| NOK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 367 | 410 | 425 | 494 |
| EBITDA | −10 | 228 | 41 | 138 |
| Net income | −132 | 104 | −67 | 7 |
| Balance sheet | ||||
| Equity | 29 | 95 | 17 | 17 |
| Total debt | 494 | 477 | 483 | 489 |
| Cash | 192 | 117 | 118 | 80 |
| Net debt | 303 | 360 | 366 | 409 |
| Ratios and per share | ||||
| EBITDA margin | −2.8% | 55.5% | 9.8% | 27.9% |
| Profit margin | −35.9% | 25.4% | −15.7% | 1.3% |
| Return on equity | −457.4% | 109.5% | −391.3% | 39.6% |
| Earnings/share (NOK) | −6.28 | 5.11 | −3.25 | 0.32 |
| Book value/share (NOK) | 1.37 | 4.66 | 0.83 | 0.81 |
| Shares outstanding (M) | 21 | 20 | 21 | 21 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 139.3 |
| P/B | 55.2 |
| EV / EBITDA | 9.6 |
| Net debt / EBITDA | 3.0 |
| Return on equity | 39.6% |
| Profit margin | 1.3% |
| Beta 1Y | 0.19 |
| Revenue growth 1Y | +16.3% |
| Revenue CAGR 3Y | +10.5% |
| ROE avg. 3Y | −80.7% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2026 | 0.47 |
| 2024 | 0.48 |
Not investment advice. Figures may contain errors from the data source.